May 12, 2026

Frozen Section in Endometrial Care?

Systematic review examines intraoperative biopsy accuracy across endometrial pathologies and diagnostic settings.

Conexiant

May 12, 2026

Rare COVID Vaccine Clotting Linked to Adenoviral Protein

Antibody proteomics and immunogenetics identify adenoviral protein VII as the trigger of PF4-targeting antibodies

The Medicine Maker

May 11, 2026

Zero-Fluoroscopy May Match Standard VA Ablation

Meta-analysis finds similar safety, success rate, recurrence risk vs. fluoroscopy-guided procedures.

Conexiant

May 11, 2026

Community ACS Initiative Reduced EMS Use

A community campaign was linked to lower emergency medical service use and slower care-seeking in high-risk communities.

Conexiant

May 11, 2026

Nodular Fasciitis May Mimic Sarcoma

Molecular testing may help avoid overtreatment when benign soft-tissue tumors present with atypical clinical or histologic features.

Conexiant

May 11, 2026

Primary Care Is Starving While Training Hospitals Feast

Internal medicine residents are choosing primary care at the lowest rates in a decade — and the system is built to make sure they do.

Conexiant

May 11, 2026

Serum Urate Goals Tied to Lower CV Risk

Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients

Conexiant

May 11, 2026

Roswell Park Study: Inhibiting Regulator Protein Can Make Aggressive Prostate Cancers More Vulnerable

Team shows BCL-2 promotes treatment resistance, uncovering strategy for making tumors respond to treatment.

Roswell Park Comprehensive Cancer Center

May 11, 2026

Roswell Park Experts Highlight Untapped Potential of CDK Inhibitor Cancer Therapy

Worldwide, more than a million breast cancer patients have been treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, which slow or stop the uncontrolled multiplication of cancer cells.

Roswell Park Comprehensive Cancer Center

May 11, 2026

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Conexiant